Drug from Biogen that treats a rare type of ALS receives fast approval from the FDA.
The Food and Drug Administration on Tuesday granted accelerated approval for Biogen’s drug tofersen,…
Biogen’s ALS medication is rejected by FDA advisors due to the disease’s rare and aggressive version.
The Food and Drug Administration’s independent panel of advisors on Wednesday declined…
Young Father Defying the Odds of ALS Says the Disease Is ‘No Longer Hopeless’.
Six months after he was given six months to live, Brian Wallach…